Ndoja, A.; Rose, C.M.; Lin, E.; Reja, R.; Petrovic, J.; Kummerfeld, S.; Blair, A.; Rizos, H.; Modrusan, Z.; Martin, S.;
et al. COP1 Deficiency in BRAFV600E Melanomas Confers Resistance to Inhibitors of the MAPK Pathway. Cells 2025, 14, 975.
https://doi.org/10.3390/cells14130975
AMA Style
Ndoja A, Rose CM, Lin E, Reja R, Petrovic J, Kummerfeld S, Blair A, Rizos H, Modrusan Z, Martin S,
et al. COP1 Deficiency in BRAFV600E Melanomas Confers Resistance to Inhibitors of the MAPK Pathway. Cells. 2025; 14(13):975.
https://doi.org/10.3390/cells14130975
Chicago/Turabian Style
Ndoja, Ada, Christopher M. Rose, Eva Lin, Rohit Reja, Jelena Petrovic, Sarah Kummerfeld, Andrew Blair, Helen Rizos, Zora Modrusan, Scott Martin,
and et al. 2025. "COP1 Deficiency in BRAFV600E Melanomas Confers Resistance to Inhibitors of the MAPK Pathway" Cells 14, no. 13: 975.
https://doi.org/10.3390/cells14130975
APA Style
Ndoja, A., Rose, C. M., Lin, E., Reja, R., Petrovic, J., Kummerfeld, S., Blair, A., Rizos, H., Modrusan, Z., Martin, S., Kirkpatrick, D. S., Heidersbach, A., Sun, T., Haley, B., Karayel, O., Newton, K., & Dixit, V. M.
(2025). COP1 Deficiency in BRAFV600E Melanomas Confers Resistance to Inhibitors of the MAPK Pathway. Cells, 14(13), 975.
https://doi.org/10.3390/cells14130975
